Maternal dementia age at onset in relation to amyloid burden in non-demented elderly offspring

Neurobiology of Aging

Volumn 40, Issue , 2016, Pages 61-67

  Maye, Jacqueline E ^a,b   Betensky, Rebecca A ^c   Gidicsin, Christopher M ^a   Locascio, Joseph ^a   Becker, J Alex ^a   Pepin, Lesley ^a   Carmasin, Jeremy ^a,d   Rentz, Dorene M ^a   Marshall, Gad A ^a   Blacker, Deborah ^a,c   Sperling, Reisa A ^a   Johnson, Keith A ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

Amyloid beta; Family history; PET; PiB

Indexed keywords

AMYLOID; AMYLOID BETA; APOLIPOPROTEIN E; PITTSBURGH COMPOUND B; UNCLASSIFIED DRUG; 2-(4'-(METHYLAMINO)PHENYL)-6-HYDROXYBENZOTHIAZOLE; AMYLOID BETA PROTEIN; ANILINE DERIVATIVE; THIAZOLE DERIVATIVE;

AGED; AGING; ALZHEIMER DISEASE; ARTICLE; DEMENTIA; DRUG RETENTION; FAMILY HISTORY; FEMALE; GESTATION PERIOD; HUMAN; IN VIVO STUDY; LONGITUDINAL STUDY; MALE; NEUROIMAGING; ONSET AGE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGENY; PROTEIN LOCALIZATION; BRAIN; DIAGNOSTIC IMAGING; EXTRACHROMOSOMAL INHERITANCE; GENETICS; METABOLISM; VERY ELDERLY;

AGE OF ONSET; AGED; AGED, 80 AND OVER; AMYLOID BETA-PEPTIDES; ANILINE COMPOUNDS; BRAIN; DEMENTIA; FEMALE; HUMANS; MALE; MATERNAL INHERITANCE; POSITRON-EMISSION TOMOGRAPHY; THIAZOLES;

EID: 84960395504     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2015.12.013     Document Type: Article

References (55)

1. Andrawis J.P., Hwang K.S., Green A.E., Kotlerman J., Elashoff D., Morra J.H., Cummings J.L., Toga A.W., Thompson P.M., Apostolova L.G. Effects of ApoE4 and maternal history of dementia on hippocampal atrophy. Neurobiol. Aging 2012, 33:856-866.
2. Atem F.D., Qian J., Maye J.E., Johnson K.A., Betensky R.A. Linear Regression with a Randomly Censored Covariate: Application to an Alzheimer's Study 2015, Available at:, (Accessed December 17, 2015). http://www.hsph.harvard.edu/rebecca-betensky/software/.
3. Bassett S.S., Avramopoulos D., Fallin D. Evidence for parent of origin effect in late-onset Alzheimer disease. Am. J. Med. Genet. 2002, 114:679-686.
4. Bassett S.S., Yousem D.M., Cristinzio C., Kusevic I., Yassa M.A., Caffo B.S., Zeger S.L. Familial risk for Alzheimer's disease alters fMRI activation patterns. Brain 2006, 129:1229-1239.
5. Baum L.W. Sex, hormones, and Alzheimer's disease. J. Gerontol. A Biol. Sci. Med. Sci. 2005, 60:736-743.
6. Becker J.A., Hedden T., Carmasin J., Maye J., Rentz D.M., Putcha D., Fischl B., Greve D.N., Marshall G.A., Salloway S., Marks D., Buckner R.L., Sperling R.A., Johnson K.A. Amyloid-β associated cortical thinning in clinically normal elderly. Ann. Neurol. 2011, 69:1032-1042.
7. Berti V., Mosconi L., Glodzik L., Li Y., Murray J., De Santi S., Pupi A., Tsui W., de Leon M.J. Structural brain changes in normal individuals with a maternal history of Alzheimer's. Neurobiol. Aging 2011, 32:2325.e17-2325.e26.
8. Bird T.D., Nemens E.J., Kukull W.A. Conjugal Alzheimer's disease: is there an increased risk in offspring?. Ann. Neurol. 1993, 65:396-399.
9. Carrasquillo M.M., Zou F., Pankratz V.S., Wilcox S.L., Younkin S.G., Younkin C.S., Younkin L.H., Bisceglio G.D., Ertekin-Taner N., Crook J.E., Dickson D.W., Petersen R.C., Graff-Radford N.R., Younkin S.G. Genetic variation in PCDH11X is associated with susceptibility to late-onset Alzheimer's disease'. Nat. Genet. 2009, 41:192-198.
10. Caso F., Agosta F., Mattavelli D., Migliaccio R., Canu E., Magnani G., Marcone A., Copetti M., Falautano M., Comi M., Comi G., Falini A., Filippi M. White matter degeneration in atypical Alzheimer's disease. Radiology 2015, 277:162-172.
11. Chan D., Janssen J.C., Whitwell J.L., Watt H.C., Jenkins R., Frost C., Rossor M.N., Fox N.C. Change in rates of cerebral atrophy over time in early-onset Alzheimer's disease: longitudinal MRI study. Lancet 2003, 362:1121-1122.
12. Choo I.H., Lee D.Y., Kim J.W., Seo E.H., Lee D.S., Kim Y.K., Kim S.G., Park S.Y., Woo J.I., Yoon E.J. Relationship of amyloid-beta burden with age-at-onset in Alzheimer disease. Am. J. Geriatr. Psychiatry 2011, 19:627-634.
13. Constancia M., Kelsey G., Relk W. Resourceful imprinting. Nature 2004, 432:53-57.
14. Coskun P., Wyrembak J., Schriner S.E., Chen H.W., Marciniack C., Laferla F., Wallace D.C. A mitochondrial etiology of Alzheimer and Parkinson disease. Biochim. Biophys. Acta 2012, 1820:553-564.
15. Duara R., Lopex-Alberola R.F., Barker W.W., Loewenstein D.A., Zatinsly M., Eisdorfer C.E., Weinberg G.B. A comparison of familial and sporadic Alzheimer's disease. Neurology 1993, 43:1377-1384.
16. Edland S.D., Silverman J.M., Peskind E.R., Tsuang D., Wijsman E., Morris J.C. Increased risk of dementia in mothers of Alzheimer's disease cases: evidence for maternal inheritance. Neurology 1996, 47:254-256.
17. Ehrenkrantz D., Silverman J.M., Smith C.J., Birstein S., Marin D., Mohs R.C., Davis K.L. Genetic epidemiological study of maternal and paternal transmission of Alzheimer's disease. Am. J. Med. Genet. 1999, 88:378-382.
18. Farrer L.A., O'Sullivan D.M., Cupples L.A., Growdon J.H., Myers R.H. Assessment of genetic risk for Alzheimer's disease among first-degree relatives. Ann. Neurol. 1989, 25:485-493.
19. Folstein M.F., Folstein S.E., McHugh P.R. "Mini-mental state." A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 1975, 12:189-198.
20. Gómez-Tortosa E., Barquero M.S., Barón M., Sainz M.J., Manzano S., Payno M., Ros R., Almaraz C., Gómez-Garré P., Jiménez-Escrig A. Variability of age at onset in siblings with familial Alzheimer disease. Arch. Neurol. 2007, 64:1743-1748.
21. Gomperts S.N., Rentz D.M., Moran E., Becker J.A., Locascio J.J., Klunk W.E., Mathis C.A., Elmaleh D.R., Shoup T., Fischman A.J., Hyman B.T., Growdon J.H., Johnson K.A. Imaging amyloid deposition in Lewy body diseases. Neurology 2008, 71:903-910.
22. Heggeli K.A., Crook J., Thomas C., Graff-Radford N. Maternal transmission of Alzheimer disease. Alzheimer Dis. Assoc. Disord. 2012, 26:364-366.
23. Ho G.J., Hansen L.A., Alford M.F., Foster K., Salmon D.P., Galasko D., Thal L.J., Masliah E. Age at onset is associated with disease severity in Lewy body variant and Alzheimer's disease. Neuroreport 2002, 13:1825-1828.
24. Honea R.A., Swerdlow R.H., Vidoni E.D., Burns J.M. Progressive regional atrophy in normal adults with a maternal history of Alzheimer disease. Neurology 2011, 76:822-829.
25. Honea R.A., Swerdlow R.H., Vidoni E.D., Goodwin J., Burns J.M. Reduced gray matter volume in normal adults with a maternal family history of Alzheimer disease. Neurology 2010, 74:113-120.
26. Honea R.A., Vidoni E.D., Swerdlow R.H., Burns J.M. Maternal family history is associated with Alzheimer's disease biomarkers. J. Alzheimer's Dis. 2012, 31:659-668.
27. Jarvik L., LaRue A., Blacker D., Gatz M., Kawas C., McArdle J.J., Morris J.C., Mortimer J.A., Ringman J.M., Ercoli L., Freimer N., Gokhman I., Manly J.J., Plassman B.L., Rasgon N., Roberts J.S., Sunderland T., Swan G.E., Wolf P.A., Zonderman A.B. Children of persons with Alzheimer disease: what does the future hold?. Alzheimer Dis. Assoc. Disord. 2008, 22:6-20.
28. Jarvik L.F., Blazer D. Children of Alzheimer patients: an overview. J. Geriatr. Psychiatry Neurol. 2005, 18:181-186.
29. Jayadev S., Steinbart E.J., Chi Y.Y., Kukull W.A., Schellenberg G.D., Bird T.D. Conjugal Alzheimer disease: risk in children when both parents have Alzheimer disease. Arch. Neurol. 2008, 65:373-378.
30. Kantarci K., Lowe V., Przybelski S.A., Weigand S.D., Senjem M.L., Ivnik R.J., Preboske G.M., Roberts R., Geda Y.E., Boeve B.F., Knopman D.S., Petersen R.C., Jack C.R. APOE modifies the association between Aβ load and cognition in cognitively normal older adults. Neurology 2012, 78:232-240.
31. Katzman R. Alzheimer's disease. New Engl. J. Med. 1986, 314:964-973.
32. Lautenschlager N.T., Cupples L.A., Rao V.S., Auerbach S.A., Becker R., Burke J., Chui H., Duara R., Foley E.J., Glatt S.L., Green R.C., Jones R., Karlinsky H., Kukull W.A., Kurz A., Larson E.B., Martelli K., Sadovnick A.D., Volicer L., Waring S.C., Growdon J.H., Farrer L.A. Risk of dementia among relatives of Alzheimer's disease patients in the MIRAGE study: what is in store for the oldest old?. Neurology 1996, 46:641-650.
33. Logan J., Fowler J.S., Volkow N.D., Wolf A.P., Dewey S.L., Schlyer D.J., MacGregor R.R., Hitzemann R., Bendriem B., Gatley S.J. Graphical analysis of reversible radioligand binding from time-activity measurements applied to [N-11C-methyl]-(-)-cocaine PET studies in human subjects. J. Cereb. Blood Flow Metab. 1990, 10:740-747.
34. Marshall G.A., Fairbanks L.A., Tekin S., Vinters H.V., Cummings J.L. Early-onset Alzheimer's disease is associated with greater pathologic burden. J. Geriatr. Psychiatry Neurol. 2007, 20:29-33.
35. Mayeux R. Epidemiology of neurodegeneration. Annu. Rev. Neurosci. 2003, 26:81-104.
36. Mayeux R. Clinical practice. Early Alzheimer's disease. N. Engl. J. Med. 2010, 362:2194-2201.
37. Miech R.A., Breitner J.C.S., Zandi P.P., Khachaturian A.S., Anthony J.C., Mayer L. Incidence of AD may decline in the early 90s for men, later for women: the Cache County study. Neurology 2002, 58:209-218.
38. Morris J.C. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology 1993, 43:2412-2414.
39. Mosconi L., Brys M., Switalski R., Mistur R., Glodzik L., Pirraglia E., Tsui W., De Santi S., de Leon M.J. Maternal family history of Alzheimer's disease predisposes to reduced brain glucose metabolism. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:19067-19072.
40. Mosconi L., Murray J., Tsui W.H., Li Y., Spector N., Goldowsky A., Williams S., Osorio R., McHugh P., Glodzik L., Vallabhajosula S., de Leon M.J. Brain imaging of cognitively normal individuals with 2 parents affected by late-onset AD. Neurology 2014, 82:752-760.
41. Mosconi L., Rinne J.O., Tsui W.H., Berti V., Li Y., Wang H., Murray J., Scheinin N., Någren K., Williams S., Glodzik L., De Santi S., Vallabhajosula S., de Leon M.J. Increased fibrillar amyloid-b burden in normal individuals with a family history of late-onset Alzheimer's. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:5949-5954.
42. Mosconi L., Rinne J.O., Tsui W.H., Murray J., Li Y., Glodzik L., Mchugh P., Williams S., Cummings M., Pirraglia E., Goldsmith S.J., Vallabhajosula S., Scheinin N., Viljanen T., Någren K., de Leon M.J. Amyloid and metabolic positron emission tomography imaging of cognitively normal adults with Alzheimer's parents. Neurobiol. Aging 2013, 34:22-34.
43. Navarro A., Boveris A. The mitochondrial energy transduction system and the aging process. Am. J. Physiol. Cell Physiol. 2007, 292:C670-C686.
44. Rabinovici G.D., Furst A.J., Alkalay A., Racine C.A., O'Neil J.P., Janabi M., Baker S.L., Agarwal N., Bonasera S.J., Mormino E.C., Weiner M.W., Gorno-Tempini M.L., Rosen H.J., Miller B.L., Jagust W.J. Increased metabolic vulnerability in early-onset Alzheimer's disease is not related to amyloid burden. Brain 2010, 133(Pt 2):512-528.
45. Reiman E.M., Chen K., Liu X., Bandy D., Yu M., Lee W., Ayutyanont N., Keppler J., Reeder S.A., Langbaum J.B.S., Alexander G.E., Klunk W.E., Mathis C.A., Price J.C., Aizenstein H.J., Dekosky S.T., Caselli R.J. Fibrillar amyloid-beta burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:6820-6825.
46. Rentz D.M., Locascio J.J., Becker J.A., Moran E.K., Eng E., Buckner R.L., Sperling R.A., Johnson K.A. Cognition, reserve and amyloid deposition in normal aging. Ann. Neurol. 2010, 67:353-364.
47. Ryan J.J., Paolo A.M. A screening procedure for estimating premorbid intelligence in the elderly. Clin. Neuropsychologist 1992, 6:53-62.
48. Silverman J.M., Ciresi G., Smith C.J., Marin D.B., Schnaider-Beeri M. Variability of familial risk of Alzheimer disease across the late life span. Arch. Gen. Psychiatry 2005, 62:565-573.
49. Silverman J.M., Smith C.J., Marin D.B., Mohs R.C., Propper C.B. Familial patterns of risk in very late-onset Alzheimer disease. Arch. Gen. Psychiatry 2003, 60:190-197.
50. Swerdlow R.H., Burns J.M., Khan S.M. The Alzheimer's disease mitochondrial cascade hypothesis. J. Alzheimers Dis. 2010, 20(Suppl 2):S265-S279.
51. Swerdlow R.H., Khan S.M. A "mitochondrial cascade hypothesis" for sporadic Alzheimer's disease. Med Hypotheses 2004, 63:8-20.
52. Swerdlow R.H., Khan S.M. The Alzheimer's disease mitochondrial cascade hypothesis: an update. Exp Neurol 2009, 218:308-315.
53. Trifunovic A., Wredenberg A., Falkenberg M., Spelbrink J.N., Rovio A.T., Bruder C.E., Bohlooly Y.M., Gidlof S., Oldfors A., Wibom R., Tornell J., Jacobs H.T., Larsson N.G. Premature ageing in mice expressing defective mitochondrial DNA polymerase. Nature 2004, 429:417-423.
54. Tzourio-Mazoyer N., Landeau B., Papathanassiou D., Crivello F., Etard O., Delcroix N., Mazoyer B., Joliot M. Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage 2002, 15:273-289.
55. Yesavage J.A., Brink T.L., Rose T.L., Lum O., Huang V., Adey M., Leirer V.O. Development and validation of a geriatric depression screening scale: a preliminary report. J. Psychiatr. Res. 1983, 17:37-49.